CDC42BPB expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 1.49659951098613E-10 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
1.379460E-04 |
Normal-vs-Stage2 |
5.49690000184455E-08 |
Normal-vs-Stage3 |
2.56461518688411E-14 |
Normal-vs-Stage4 |
2.14284145982901E-12 |
Stage1-vs-Stage2 |
2.115700E-03 |
Stage1-vs-Stage3 |
1.22400000135414E-08 |
Stage1-vs-Stage4 |
1.14739999945712E-07 |
Stage2-vs-Stage3 |
4.474200E-01 |
Stage2-vs-Stage4 |
2.326000E-01 |
Stage3-vs-Stage4 |
4.822400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
3.69300146019214E-11 |
Normal-vs-AfricanAmerican |
1.046470E-02 |
Normal-vs-Asian |
2.625600E-01 |
Caucasian-vs-AfricanAmerican |
9.933800E-02 |
Caucasian-vs-Asian |
2.216200E-01 |
AfricanAmerican-vs-Asian |
7.368600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
1.67249547544657E-11 |
Normal-vs-Female |
1.7349999999916E-05 |
Male-vs-Female |
1.498810E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
3.246400E-04 |
Normal-vs-Age(41-60Yrs) |
2.36089999994249E-07 |
Normal-vs-Age(61-80Yrs) |
9.75629577126824E-11 |
Normal-vs-Age(81-100Yrs) |
2.4840000000248E-06 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.759200E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.724800E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.624000E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.517900E-02 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.881800E-02 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.812400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
6.867900E-02 |
Normal-vs-Grade 2 |
2.2895999999939E-05 |
Normal-vs-Grade 3 |
1.78645986892434E-12 |
Normal-vs-Grade 4 |
1.62547753035369E-12 |
Grade 1-vs-Grade 2 |
8.778000E-04 |
Grade 1-vs-Grade 3 |
4.49699999460762E-08 |
Grade 1-vs-Grade 4 |
6.58859966584657E-10 |
Grade 2-vs-Grade 3 |
1.68900999999444E-05 |
Grade 2-vs-Grade 4 |
9.13080000497501E-09 |
Grade 3-vs-Grade 4 |
1.201500E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
6.20630000000011E-05 |
Normal-vs-ccB subtype |
2.48919773682132E-11 |
ccA subtype-vs-ccB subtype |
4.442300E-04 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
1.20359999744579E-09 |
Normal-vs-N1 |
9.63040003298943E-09 |
N0-vs-N1 |
1.822270E-02 |
|
|